Some Medicare prescription drug plans and Medicare Advantage plans will cover part of the cost of Forteo injections for osteoporosis. Read about costs here.

The approval is based on data from the PF708-301 phase 3 study which showed comparable overall profiles between Bonsity and Forteo after 24 weeks of daily injection in osteoporosis patients.

Forteo had annual sales of $609 million as of July 2023, according to IQVIA data. Teva's generic equivalent of Forteo (teriparatide injection) utilizes the Antares Pharma, Inc. multi-dose pen device.

Teva Pharmaceuticals announced FDA approval of a generic version of Forteo in the U.S. for certain women and men with osteoporosis, according to a company press release.The generic equivalent of ...